MedTrace Logo

Reward Sensitivity Digital Intervention for Suicide Risk

NCT07661901 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2026-06-22

No results posted yet for this study

Summary

The goal of this clinical trial is to develop and test an app designed to reduce suicide risk and improve emotional well-being in adolescents. The study will test if the app's daily check ins and recommended mood boosting skills will improve the adolescent's overall mood and suicidality. The main question it aims to answer is:

• Is the app practical and acceptable to use daily?

In the study, adolescents will:

* Participate in a focus group with other adolescents and provide feedback on the app itself (design, ease of use, etc.).
* Complete surveys and assessments on their mood, thoughts, and experiences.
* Complete assessments about their app experience.

In the study, the legal guardian of the adolescent will:

* Participate in a focus group with other adolescents and provide feedback on the app itself (design, ease of use, etc.).
* Complete assessments about their app experience.

Conditions

  • Suicidal Ideation
  • Suicidal
  • Suicidal Thoughts
  • Digital Health Intervention
  • Reward Sensitivity
  • Anhedonia

Interventions

BEHAVIORAL

Suicide prevention treatment

Digital just-in-time adaptive intervention to enhance reward sensitivity and reduce suicidal ideation

Sponsors & Collaborators

Principal Investigators

  • Marin Kautz, Ph.D. · University of Pennsylvania

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
13 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-30
Primary Completion
2027-06-30
Completion
2027-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07661901 on ClinicalTrials.gov